Both Dilantin and Ortho-Cyclen offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Dilantin and Ortho-Cyclen have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Dilantin has a lower risk of dependency, making it a safer option for patients concerned about addiction.

Ortho-Cyclen offers greater flexibility with different delivery forms, making it suitable for patients with specific preferences or medical needs.

Dilantin has fewer contraindications, making it suitable for a broader range of patients, including those with comorbidities.

Both drugs offer advantages depending on treatment goals. Dilantin is great for fast relief, while Ortho-Cyclen is better for long-term management. The choice depends on the patient’s specific needs.